Is Wall Street Right About Intuitive Surgical?
While Intuitive Surgical has long been a Motley Fool favorite and a darling of the stock market, it has been a difficult month for the stock, coming down 5% and being targeted by short seller Citron Research. In this video, Motley Fool health care analyst David Williamson takes us through Wall Street's bullish stance on the stock, but also how Intuitive Surgical could be negatively affected by the pressure to lower health care costs.
Despite its recent sell-off this month, Intuitive Surgical has been a longtime pick of Motley Fool superinvestor David Gardner, and has soared 1,002.94% since he recommended it in March 2005. David specializes in identifying game-changing companies like this long before others are keen to their disruptive potential, and he helps like-minded investors profit while Wall Street catches up. I invite you to learn more about how he picks his winners with a free, personal tour of his flagship service: Supernova. Inside, you'll discover the science behind his market-trouncing returns. Just click here now for instant access.
The article Is Wall Street Right About Intuitive Surgical? originally appeared on Fool.com.David Williamson has no position in any stocks mentioned. Follow him on Twitter @MotleyDavid. Max Macaluso has no position in any stocks mentioned. The Motley Fool recommends Intuitive Surgical. The Motley Fool owns shares of Intuitive Surgical. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.